DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sulentic C.E.W. | ko |
dc.contributor.author | Kang J.S. | ko |
dc.contributor.author | Na Y.J. | ko |
dc.contributor.author | Kaminski N.E. | ko |
dc.date.accessioned | 2013-03-04T12:38:22Z | - |
dc.date.available | 2013-03-04T12:38:22Z | - |
dc.date.created | 2012-02-06 | - |
dc.date.created | 2012-02-06 | - |
dc.date.issued | 2004-08 | - |
dc.identifier.citation | TOXICOLOGY, v.200, no.2-3, pp.235 - 246 | - |
dc.identifier.issn | 0300-483X | - |
dc.identifier.uri | http://hdl.handle.net/10203/82662 | - |
dc.description.abstract | Our previous results describing the CH12.LX (AhR-expressing) and BCL-1 (AhR-deficient) B cell lines have supported an AhR/dioxin-responsive element (DRE)-mediated mechanism for TCDD-induced inhibition of mu heavy chain expression and thus of IgM secretion. Transcriptional regulation of the Ig heavy chain genes involves several regulatory elements including the 3'alpha Ig heavy chain enhancer, which is composed of four regulatory domains that span approximately 40 kb. One of these domains, hs4, contains a DRE-like site that overlaps a kappaB motif. We have previously demonstrated TCDD-inducible binding of both the AhR nuclear complex and NF-kappaB/Rel proteins to the DRE and kappaB motifs, respectively, as well as TCDD and LPS-induced transcriptional activity through the hs4 domain. The objective of the present study was to determine if the AhR nuclear complex and NF-kappaB/Rel proteins converge at these two overlapping cis-elements and act cooperatively to influence enhancer activity. To eliminate the potential influence of other transcription factors which bind to the hs4 domain, the approach was to construct a series of luciferase reporters containing a variable heavy chain (V-H) promoter and a 42 bp fragment of the 1.4 kb hs4 regulatory domain, that included only the overlapping DRE and kappaB motif or mutations of these motifs for transient transfection experiments in CH12.LX and BCL-1 cells. In the CH12.LX cells, TCDD activated the hs4 fragment; however, co-treatment with LPS led to a marked and synergistic activation as previously observed with the wild type 1.4 kb hs4 domain. Mutation of either or both of the DRE and kappaB motifs diminished the effect of TCDD and LIPS on the luciferase reporters possessing the 42 bp portion of hs4, and resembled the effect of these treatments on the promoter alone. In the BCL-1 cells, activity of the hs4 fragment was not induced by TCDD and/or LPS treatment. These results suggest that the AhR nuclear complex and NF-kappaB/Rel proteins converge at the DRE and kappaB motif to influence transcriptional activity of the hs4 enhancer fragment. (C) 2004 Elsevier Ireland Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER SCI IRELAND LTD | - |
dc.subject | ARYL-HYDROCARBON RECEPTOR | - |
dc.subject | LOCUS-CONTROL REGION | - |
dc.subject | C-MYC EXPRESSION | - |
dc.subject | CELL DIFFERENTIATION | - |
dc.subject | AH-RECEPTOR | - |
dc.subject | 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD | - |
dc.subject | TRANSCRIPTIONAL ACTIVATION | - |
dc.subject | NUCLEAR TRANSLOCATOR | - |
dc.subject | IMMUNE-RESPONSES | - |
dc.subject | DNA-BINDING | - |
dc.title | Interactions at a dioxin responsive element (DRE) and an overlapping kappa B site within the hs4 domain of the 3 'alpha immunoglobulin heavy chain enhancer | - |
dc.type | Article | - |
dc.identifier.wosid | 000222671800014 | - |
dc.identifier.scopusid | 2-s2.0-2942746223 | - |
dc.type.rims | ART | - |
dc.citation.volume | 200 | - |
dc.citation.issue | 2-3 | - |
dc.citation.beginningpage | 235 | - |
dc.citation.endingpage | 246 | - |
dc.citation.publicationname | TOXICOLOGY | - |
dc.identifier.doi | 10.1016/j.tox.2004.03.015 | - |
dc.contributor.localauthor | Na Y.J. | - |
dc.contributor.nonIdAuthor | Sulentic C.E.W. | - |
dc.contributor.nonIdAuthor | Kang J.S. | - |
dc.contributor.nonIdAuthor | Kaminski N.E. | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordAuthor | B lymphocyte | - |
dc.subject.keywordAuthor | NF-kappa B/Rel | - |
dc.subject.keywordAuthor | AhR | - |
dc.subject.keywordAuthor | 2,3,7,8-tetrachlorodibenzo-p-dioxin | - |
dc.subject.keywordAuthor | lipopolysaccharide | - |
dc.subject.keywordAuthor | CH12.LX | - |
dc.subject.keywordAuthor | BCL-1 | - |
dc.subject.keywordPlus | ARYL-HYDROCARBON RECEPTOR | - |
dc.subject.keywordPlus | LOCUS-CONTROL REGION | - |
dc.subject.keywordPlus | C-MYC EXPRESSION | - |
dc.subject.keywordPlus | CELL DIFFERENTIATION | - |
dc.subject.keywordPlus | AH-RECEPTOR | - |
dc.subject.keywordPlus | 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD | - |
dc.subject.keywordPlus | TRANSCRIPTIONAL ACTIVATION | - |
dc.subject.keywordPlus | NUCLEAR TRANSLOCATOR | - |
dc.subject.keywordPlus | IMMUNE-RESPONSES | - |
dc.subject.keywordPlus | DNA-BINDING | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.